| Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug resistant cancer cells AM Chen, M Zhang, D Wei, D Stueber, O Taratula, T Minko, H He Small (Weinheim an der Bergstrasse, Germany) 5 (23), 2673, 2009 | 753 | 2009 |
| Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA O Taratula, A Kuzmov, M Shah, OB Garbuzenko, T Minko Journal of controlled release 171 (3), 349-357, 2013 | 407 | 2013 |
| Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer R Savla, O Taratula, O Garbuzenko, T Minko Journal of controlled release 153 (1), 16-22, 2011 | 398 | 2011 |
| Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery O Taratula, OB Garbuzenko, P Kirkpatrick, I Pandya, R Savla, ... Journal of Controlled Release 140 (3), 284-293, 2009 | 392 | 2009 |
| Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting ML Patil, M Zhang, O Taratula, OB Garbuzenko, H He, T Minko Biomacromolecules 10 (2), 258-266, 2009 | 280 | 2009 |
| Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery ML Patil, M Zhang, S Betigeri, O Taratula, H He, T Minko Bioconjugate chemistry 19 (7), 1396-1403, 2008 | 268 | 2008 |
| DNA and carbon nanotubes as medicine W Cheung, F Pontoriero, O Taratula, AM Chen, H He Advanced drug delivery reviews 62 (6), 633-649, 2010 | 265 | 2010 |
| Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA O Taratula, OB Garbuzenko, AM Chen, T Minko Journal of drug targeting 19 (10), 900-914, 2011 | 261 | 2011 |
| Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells Y Xiao, X Gao, O Taratula, S Treado, A Urbas, RD Holbrook, RE Cavicchi, ... BMC cancer 9, 1-11, 2009 | 217 | 2009 |
| Nanocarrier-based systems for targeted and site specific therapeutic delivery J Majumder, O Taratula, T Minko Advanced drug delivery reviews 144, 57-77, 2019 | 194 | 2019 |
| Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug V Shah, O Taratula, OB Garbuzenko, OR Taratula, ... Clinical Cancer Research 19 (22), 6193-6204, 2013 | 191 | 2013 |
| Biocompatible nanoclusters with high heating efficiency for systemically delivered magnetic hyperthermia HA Albarqi, LH Wong, C Schumann, FY Sabei, T Korzun, X Li, ... ACS nano 13 (6), 6383-6395, 2019 | 180 | 2019 |
| Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes O Taratula, O Garbuzenko, R Savla, Y Andrew Wang, H He, T Minko Current drug delivery 8 (1), 59-69, 2011 | 168 | 2011 |
| A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy O Taratula, C Schumann, MA Naleway, AJ Pang, KJ Chon, O Taratula Molecular pharmaceutics 10 (10), 3946-3958, 2013 | 166 | 2013 |
| Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention OB Garbuzenko, G Mainelis, O Taratula, T Minko Cancer biology & medicine 11 (1), 44, 2014 | 152 | 2014 |
| Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy O Taratula, C Schumann, T Duong, KL Taylor, O Taratula Nanoscale 7 (9), 3888-3902, 2015 | 139 | 2015 |
| Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo-and gene therapy OB Garbuzenko, A Kuzmov, O Taratula, SR Pine, T Minko Theranostics 9 (26), 8362, 2019 | 105 | 2019 |
| Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids V Shah, O Taratula, O B Garbuzenko, M L Patil, R Savla, M Zhang, ... Current drug discovery technologies 10 (1), 8-15, 2013 | 97 | 2013 |
| Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells O Taratula, RK Dani, C Schumann, H Xu, A Wang, H Song, P Dhagat, ... International journal of pharmaceutics 458 (1), 169-180, 2013 | 88 | 2013 |
| Precision targeted therapy of ovarian cancer J Sapiezynski, O Taratula, L Rodriguez-Rodriguez, T Minko Journal of Controlled Release 243, 250-268, 2016 | 85 | 2016 |
